Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05728333
PHASE2/PHASE3

Intravenous Tirofiban Versus Alteplase Before Mechanical Thrombectomy in Stroke

Sponsor: Xinqiao Hospital of Chongqing

View on ClinicalTrials.gov

Summary

In patients with acute ischemic stroke secondary to large vessel occlusion, the role of intravenous adjunctive medications, such as tirofiban, or alteplase before endovascular thrombectomy has not been well investigated. This trial aim to evaluate the efficacy and safety of intravenous tirofiban versus alteplase for acute ischemic stroke patients with large vessel occlusion piror to endovascular thrombectomy.

Official title: Intravenous Adjuvant With Tirofiban Versus Alteplase Before Mechanical Thrombectomy in Acute Ischemic Stroke Patients With Large Vessel Occlusion: a Multicenter, Open Label, Randomized Controlled Trial.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

800

Start Date

2023-11-28

Completion Date

2026-07-31

Last Updated

2025-12-26

Healthy Volunteers

No

Interventions

DRUG

Tirofiban

Intravenous tirofiban before endovascular thrombectomy.

DRUG

Alteplase

Intravenous alteplase before endovascular thrombectomy.

Locations (1)

Hangzhou First People's Hospital

Hangzhou, Zhejiang, China